Skip to main content

Published locations for BRAFV600E mCRC: No survival benefit of FOLFOXIRI+anti-VEGF over doublet+anti-VEGF

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. BRAFV600E mCRC: No survival benefit of FOLFOXIRI+anti-VEGF over doublet+anti-VEGF

User login

  • Reset your password
  • /content/brafv600e-mcrc-no-survival-benefit-folfoxirianti-vegf-over-doubletanti-vegf
  • /hematology-oncology/article/257934/gastrointestinal-cancer/brafv600e-mcrc-no-survival-benefit